PLSE vs MDU
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PLSE · Pulse Biosciences$53.29 ▲ 0.41%
MDU · MDU Resources$18.63 ▲ 0.54%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PLSE +247.1%
- MDU -9.2%
Head to head
| Metric | PLSE | MDU |
|---|---|---|
| Price | $53.29 | $18.63 |
| Change today | ▲ 0.41% | ▲ 0.54% |
| Market cap | $3.92B | $3.92B |
| Return, 3 months | +28.4% | -8.0% |
| Return, year to date | +288.1% | -2.6% |
| Return, 1 year | +244.7% | -8.3% |
| P/E (TTM) | – | 20.3 |
| P/B | 21.4 | 1.3 |
| P/E percentile vs own 5y | 2nd | 83rd |
| Dividend yield | – | 3.01% |
| Revenue growth (YoY, latest qtr) | – | +6.9% |
| Net profit growth (YoY) | -28.6% | +54.1% |
| Gross margin | 0.3% | 34.8% |
| Operating margin | -7,007.8% | 17.0% |
| Net margin | -6,755.8% | 10.7% |
| Return on equity | -78.5% | 7.0% |
| Analyst target vs. price | +17.0% | +30.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 53 | 40 |
| 30-day volatility | 65.9% | 23.8% |
| Max drawdown, 1 year | -29.5% | -18.2% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PLSE is the largest of the group by market value.
- PLSE has returned the most over the past year.
- MDU keeps the most profit per dollar of sales.
- MDU has been the calmest stock over the last 30 days.